1. Evaluating response to immunotherapy with ¹⁸F-FDG PET/CT: where do we stand?

   • Nicolas Aide
   • Michel De Pontdeville
   • Egesta Lopci

   Editorial 30 January 2020 Pages: 1019 - 1021

   

2. Imaging features of 2019 novel coronavirus pneumonia

   • Xi Xu
   • Chengcheng Yu
   • Jinxin Liu

   Letter to the Editor 14 February 2020 Pages: 1022 - 1023

   

3. “Luke! Luke! Don’t! It’s a trap!”—spotlight on bias in animal experiments in nuclear oncology

   • Julie Nonnekens
   • Margret Schottelius

   Letter to the Editor Open access 10 February 2020 Pages: 1024 - 1026

4. In vivo three-dimensional evaluation of tumour hypoxia in nasopharyngeal carcinomas using FMT-CT and MSOT

   • Wenhui Huang
   • Kun Wang
   • Shuixing Zhang

   Original Article Open access 08 November 2019 Pages: 1027 - 1038

   

5. High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma

   • Jakob Schmidt Jensen
   • Julie Thor Christensen
   • Jacob Høygaard Rasmussen

   Original Article 13 November 2019 Pages: 1039 - 1045

   

6. Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial

   • Nils H. Nicolay
   • Nicole Wiedenmann
   • Gian Kayser

   Original Article 07 December 2019 Pages: 1046 - 1055

   

7. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy

   • A. Sörensen
   • M. Carles
   • M. Mix

   Original Article 26 November 2019 Pages: 1056 - 1064

   

8. Usefulness of [¹⁸F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma

   • Liang Zhao
   • Yanzhen Zhuang
   • Qin Lin

   Original Article 14 December 2020 Pages: 1065 - 1074

   

9. Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study

   • Nils Helsen
   • Tim Van den Wyngaert
   • Kristof Deben

   Original Article 10 February 2020 Pages: 1075 - 1082

   

10. ¹⁸F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study

    • Chunxia Qin
    • Fuqiang Shao
    • Xiaoli Lan

    Original Article 05 December 2019 Pages: 1083 - 1093

    

11. The feasibility of quantitative parameters of lymphoscintigraphy without significant dermal backflow for the evaluation of lymphedema in post-operative patients with breast cancer

    • Keunyoung Kim
    • In-Joo Kim
    • Jin A Yoon

    Original Article 16 November 2019 Pages: 1094 - 1102

    

12. Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass ¹⁸F-FDG PET/CT

    • Neree Payan
    • Benoit Presles
    • Alexandre Cochet

    Original Article 08 August 2019 Pages: 1103 - 1115

    

13. ¹⁸F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients

    • Panli Li
    • Xiuying Wang
    • Gang Huang

    Original Article 25 January 2020 Pages: 1116 - 1126

    

14. New insight on the correlation of metabolic status on ¹⁸F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer

    • Yang Wang
    • Ning Zhao
    • Xiubao Ren

    Original Article 09 September 2019 Pages: 1127 - 1136

    

15. Value of pre-therapy ¹⁸F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer

    • Jianyuan Zhang
    • Xinming Zhao
    • Jingya Han

    Original Article 14 November 2019 Pages: 1137 - 1146

    

16. Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors

    • Romain-David Seban
    • Laura Mezquita
    • Benjamin Besse

    Original Article 21 November 2019 Pages: 1147 - 1157

    

17. ¹⁸FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns

    • O. Humbert
    • N. Cadour
    • J. Otto

    Original Article 23 November 2019 Pages: 1158 - 1167

    

18. Radiomics of ¹⁸F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy

    • Wei Mu
    • Ilke Tunali
    • Robert J. Gillies

    Original Article 05 December 2019 Pages: 1168 - 1182

    

19. Correlation between combining ¹⁸F–FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer

    • Maomei Ruan
    • Liu Liu
    • Wenhui Xie

    Original Article 03 January 2020 Pages: 1183 - 1197

    

20. Influx rate constant of ¹⁸F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients

    • Min Yang
    • Zhong Lin
    • Hongjun Jin

    Original Article 23 January 2020 Pages: 1198 - 1208

    

21. The efficiency of ¹⁸F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

    • Xiuli Tao
    • Ning Li
    • Zewei Zhang

    Original Article Open access 11 February 2020 Pages: 1209 - 1219

    

22. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy

    • Suman Shrestha
    • Tetsuya Higuchi
    • Yoshito Tsushima

    Original Article Open access 22 November 2019 Pages: 1220 - 1227

    

23. The role of ¹⁸F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study

    • Vittoria Rufini
    • Angela Collarino
    • Alessandro Giordano

    Original Article 14 August 2019 Pages: 1228 - 1238

    

24. [¹⁸F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer

    • Rohini Sharma
    • Pablo Oriol Valls
    • Eric O. Aboagye

    Original Article Open access 21 November 2019 Pages: 1239 - 1251

    

25. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer

    • A. Martinez
    • M. Voglimacci
    • E. Gabiache

    Original Article 08 January 2020 Pages: 1252 - 1260

    

26. Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel

    • Angela Collarino
    • Valentina Fuoco
    • Marco Maccauro

    Review Article 02 January 2020 Pages: 1261 - 1274

    

27. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

    • Xi Xu
    • Chengcheng Yu
    • Jinxin Liu

    Original Article 28 February 2020 Pages: 1275 - 1280

    

28. ¹⁸F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

    • Chunxia Qin
    • Fang Liu
    • Xiaoli Lan

    Short Communication 22 February 2020 Pages: 1281 - 1286

    

29. Diagnostic performance of ¹⁸F-FDG PET/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis

    • Giorgio Treglia
    • Mariarosa Pascale
    • Andor W. J. M. Glaudemans

    Review Article 15 November 2019 Pages: 1287 - 1301

    

30. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody

    • Camilla Christensen
    • Lotte K. Kristensen
    • Andreas Kjaer

    Original Article Open access 27 December 2019 Pages: 1302 - 1313

    

31. Using immuno-PET imaging to monitor kinetics of T cell-mediated inflammation and treatment efficiency in a humanized mouse model for GvHD

    • Stefanie Pektor
    • Janine Schlöder
    • Matthias Miederer

    Original Article 31 August 2019 Pages: 1314 - 1325

    

32. McCune-Albright syndrome confirmed by ^99mTc-MDP

    • Ruiguo Zhang
    • Peng Wang
    • Jian Tan

    Image of the Month 13 September 2019 Pages: 1326 - 1328

    

33. Augmented planar bone scintigraphy obtained from a whole-body SPECT recording of less than 20 min with a high-sensitivity 360° CZT camera

    • Saifeddine Melki
    • Mohammad Bilal Chawki
    • Antoine Verger

    Image of the Month 12 October 2019 Pages: 1329 - 1331